Documentos relacionados

1. Plasmablastic light chain myeloma presenting as pancytopenia: An unusual presentation.
2. Development of novel methods for non-canonical myeloma protein analysis with an innovative adaptation of immunofixation electrophoresis, native top-down mass spectrometry, and middle-down <i>de novo</i> sequencing.
3. Investigating the utility of saliva immunoglobulins for the detection of myeloma and using myeloma proteins to clarify partition between oral and systemic immunity.
4. [The Accurate Quantification of Monoclonal Immunoglobulin by A Capillary Electrophoresis System].
5. Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein.
6. Therapeutic Advances in the Management of Smoldering Myeloma.
7. Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma.
8. Immunochemical studies on mouse myeloma proteins reactive with dextrans or with fructosans and on human antilevans.
9. [Expression and significance of HSP90 in plasma of patients with multiple myeloma].
10. Complete covalent structure of a human IgA1 immunoglobulin.